SCHEMBL19850160

SCHEMBL19850160

N#Cc1cc(C#N)cc(-c2cccc3c4cccc(-c5cc(C#N)cc(C#N)c5)c4n(-c4cccc5c4C(=O)N(c4cc(-c6ccccc6)cc(-c6ccccc6)c4)C5=O)c23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE6D O43924 1/20 0.37
▸ PDCD1 Q15116 4/20 0.35
▸ CD274 Q9NZQ7 4/20 0.35
▸ HSPA1A P0DMV8 1/20 0.35
▸ PABPC1 P11940 1/20 0.35
▸ TYMS P04818 1/20 0.35
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ USP2 O75604 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ TNNI3 P19429 1/20 0.34
▸ TNNT2 P45379 1/20 0.34
▸ TNNC1 P63316 1/20 0.34
▸ GRM5 P41594 1/20 0.34
▸ PTGES O14684 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19843225 0.95 PDE6D (0.35) PDE6DPDCD1CD274HSPA1APABPC1
SCHEMBL19842880 0.94 HTT (0.39) PDE6DPDCD1CD274HSPA1APABPC1
SCHEMBL19842561 0.94 PDCD1 (0.39) PDE6DPDCD1CD274HSPA1APABPC1
SCHEMBL19842643 0.93 PDE6D (0.45) PDE6DPDCD1CD274HSPA1APABPC1
SCHEMBL19850159 0.92 PDE6D (0.39) PDE6DPDCD1CD274HSPA1APABPC1
SCHEMBL19843392 0.91 BACE1 (0.35) PDE6DPDCD1CD274HSPA1APABPC1
SCHEMBL19842877 0.89 HTT (0.37) PDE6DPDCD1CD274HSPA1APABPC1
SCHEMBL19842996 0.89 PDCD1 (0.36) PDE6DPDCD1CD274TYMSKMT2A
SCHEMBL19842760 0.89 NR1H2 (0.43) PDE6DPDCD1CD274TYMSKMT2A
SCHEMBL19842471 0.88 PDE6D (0.43) PDE6DHSPA1APABPC1TYMSKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3494112-B1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2022-04-20 — — EP disclosed
US-20210171501-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-10 — — US disclosed
WO-2018024725-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171501-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES L1CAM, OR10J3, AOX1 PDE6D 923/4885PDCD1 3138/4885CD274 1124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback